|
|
Volumn 26, Issue 8, 2008, Pages 841-842
|
|
Myriad stumbles, Wyeth closes on Alzheimer's
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMYLOID BETA PROTEIN;
APOLIPOPROTEIN E4;
BAPINEUZUMAB;
CHOLINESTERASE INHIBITOR;
DIMEBON;
GAMMA SECRETASE;
GAMMA SECRETASE INHIBITOR;
LEUPRORELIN;
N2 [2 (3,5 DIFLUOROPHENYL) 2 HYDROXYACETYL] N1 (6,7 DIHYDRO 5 METHYL 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL)ALANINAMIDE;
NEFIRACETAM;
NERAMEXANE;
NONSTEROID ANTIINFLAMMATORY AGENT;
ROSIGLITAZONE;
SEMAGACESTAT;
TARENFLURBIL;
UNCLASSIFIED DRUG;
VP 4896;
ALZHEIMER DISEASE;
DRUG INDUSTRY;
DRUG MECHANISM;
DRUG RESEARCH;
NOTE;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
STATISTICAL SIGNIFICANCE;
TREATMENT RESPONSE;
ALZHEIMER DISEASE;
ANTIBODIES, MONOCLONAL;
DRUG DESIGN;
DRUG INDUSTRY;
HUMANS;
|
|
EID: 49449097504
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0808-841 Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
